The role of podoplanin inhibitors in controlling oral cancer progression
Objective: In this article, we review the current studies on the role of podoplanin in oral cancer and the potential application of podoplanin inhibitors as a therapeutic agent for oral cancer. Design: The narrative review approach was conducted, providing a comprehensive perspective of related li...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English English |
Published: |
Elsevier Ltd. All
2023
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/108063/7/108063_The%20role%20of%20podoplanin%20inhibitors.pdf http://irep.iium.edu.my/108063/13/108063_The%20role%20of%20podoplanin%20inhibitors_Scopus.pdf http://irep.iium.edu.my/108063/ https://www.sciencedirect.com/science/article/pii/S0003996923002297?dgcid=author https://doi.org/10.1016/j.archoralbio.2023.105841 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.iium.irep.108063 |
---|---|
record_format |
dspace |
spelling |
my.iium.irep.1080632024-01-08T05:29:10Z http://irep.iium.edu.my/108063/ The role of podoplanin inhibitors in controlling oral cancer progression Engku Ngah Sayuddin, Engku Nasiha Bakhtiar, Muhammad Taher Arzmi, Mohd Hafiz Burhanudin, Nor Aszlitah Rostam, Muhamad Ashraf RK Dentistry RM Therapeutics. Pharmacology Objective: In this article, we review the current studies on the role of podoplanin in oral cancer and the potential application of podoplanin inhibitors as a therapeutic agent for oral cancer. Design: The narrative review approach was conducted, providing a comprehensive perspective of related literature. Publications addressing podoplanin and its inhibitors in the context of oral cancer were retrieved from PubMed and Scopus databases. Results: Podoplanin has emerged as a biomarker and therapeutic agent for oral cancer. Numerous studies have reported high podoplanin expression in oral cancer and pre-cancerous lesions compared to normal cells. A specific inhibitor targeting podoplanin may have the potential to prevent oral carcinogenesis via interfering with the pathway of cancerous cells involved in cell proliferation and metastasis. Antibodies, chimeric antigen receptor (CAR)-T cells, cancer-specific mAb (CasMab), synthetic molecules, and lectins are among the materials used as anticancer agents targeting podoplanin. Plant-derived lectins appear to demonstrate a unique advantage against alternative candidates. Conclusions: The use of podoplanin inhibitors in place of existing therapeutic approaches could be a promising and novel approach to the prevention and treatment of oral cancer. Nevertheless, further research is required to investigate the practical application of such inhibitors. Elsevier Ltd. All 2023-11-01 Article PeerReviewed application/pdf en http://irep.iium.edu.my/108063/7/108063_The%20role%20of%20podoplanin%20inhibitors.pdf application/pdf en http://irep.iium.edu.my/108063/13/108063_The%20role%20of%20podoplanin%20inhibitors_Scopus.pdf Engku Ngah Sayuddin, Engku Nasiha and Bakhtiar, Muhammad Taher and Arzmi, Mohd Hafiz and Burhanudin, Nor Aszlitah and Rostam, Muhamad Ashraf (2023) The role of podoplanin inhibitors in controlling oral cancer progression. Archives of Oral Biology, 157. pp. 1-7. ISSN 0003-9969 E-ISSN 1879-1506 https://www.sciencedirect.com/science/article/pii/S0003996923002297?dgcid=author https://doi.org/10.1016/j.archoralbio.2023.105841 |
institution |
Universiti Islam Antarabangsa Malaysia |
building |
IIUM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
International Islamic University Malaysia |
content_source |
IIUM Repository (IREP) |
url_provider |
http://irep.iium.edu.my/ |
language |
English English |
topic |
RK Dentistry RM Therapeutics. Pharmacology |
spellingShingle |
RK Dentistry RM Therapeutics. Pharmacology Engku Ngah Sayuddin, Engku Nasiha Bakhtiar, Muhammad Taher Arzmi, Mohd Hafiz Burhanudin, Nor Aszlitah Rostam, Muhamad Ashraf The role of podoplanin inhibitors in controlling oral cancer progression |
description |
Objective: In this article, we review the current studies on the role of podoplanin in oral cancer and the potential
application of podoplanin inhibitors as a therapeutic agent for oral cancer.
Design: The narrative review approach was conducted, providing a comprehensive perspective of related literature.
Publications addressing podoplanin and its inhibitors in the context of oral cancer were retrieved from
PubMed and Scopus databases.
Results: Podoplanin has emerged as a biomarker and therapeutic agent for oral cancer. Numerous studies have
reported high podoplanin expression in oral cancer and pre-cancerous lesions compared to normal cells. A
specific inhibitor targeting podoplanin may have the potential to prevent oral carcinogenesis via interfering with
the pathway of cancerous cells involved in cell proliferation and metastasis. Antibodies, chimeric antigen receptor
(CAR)-T cells, cancer-specific mAb (CasMab), synthetic molecules, and lectins are among the materials
used as anticancer agents targeting podoplanin. Plant-derived lectins appear to demonstrate a unique advantage
against alternative candidates.
Conclusions: The use of podoplanin inhibitors in place of existing therapeutic approaches could be a promising
and novel approach to the prevention and treatment of oral cancer. Nevertheless, further research is required to
investigate the practical application of such inhibitors. |
format |
Article |
author |
Engku Ngah Sayuddin, Engku Nasiha Bakhtiar, Muhammad Taher Arzmi, Mohd Hafiz Burhanudin, Nor Aszlitah Rostam, Muhamad Ashraf |
author_facet |
Engku Ngah Sayuddin, Engku Nasiha Bakhtiar, Muhammad Taher Arzmi, Mohd Hafiz Burhanudin, Nor Aszlitah Rostam, Muhamad Ashraf |
author_sort |
Engku Ngah Sayuddin, Engku Nasiha |
title |
The role of podoplanin inhibitors in controlling oral cancer progression |
title_short |
The role of podoplanin inhibitors in controlling oral cancer progression |
title_full |
The role of podoplanin inhibitors in controlling oral cancer progression |
title_fullStr |
The role of podoplanin inhibitors in controlling oral cancer progression |
title_full_unstemmed |
The role of podoplanin inhibitors in controlling oral cancer progression |
title_sort |
role of podoplanin inhibitors in controlling oral cancer progression |
publisher |
Elsevier Ltd. All |
publishDate |
2023 |
url |
http://irep.iium.edu.my/108063/7/108063_The%20role%20of%20podoplanin%20inhibitors.pdf http://irep.iium.edu.my/108063/13/108063_The%20role%20of%20podoplanin%20inhibitors_Scopus.pdf http://irep.iium.edu.my/108063/ https://www.sciencedirect.com/science/article/pii/S0003996923002297?dgcid=author https://doi.org/10.1016/j.archoralbio.2023.105841 |
_version_ |
1787520328195375104 |
score |
13.209306 |